Literature DB >> 19520771

Subtilisin-like proprotein convertase PACE4 is required for skeletal muscle differentiation.

Keizo Yuasa1, Tetsuya Masuda, Chihiro Yoshikawa, Masami Nagahama, Yoshiko Matsuda, Akihiko Tsuji.   

Abstract

Most growth factors stimulate myoblast proliferation and prevent differentiation, whereas insulin-like growth factors (IGFs) promote myoblast differentiation through the phosphatidylinositol 3-kinase (PI3K) pathway. Subtilisin-like proprotein convertases (SPCs) are involved in cell growth and differentiation via activation of pro-growth factors. However, the role of SPCs in myogenesis remains poorly understood. Here we show that PACE4, a member of the SPC family, plays a critical role in myogenic differentiation of C2C12 cells. PACE4 mRNA levels increased markedly during myogenesis, whereas the expression of other member of SPC family, furin and PC6, remained unchanged. The expression pattern of pro-IGF-II, which is processed extracellularly by SPCs, was similar to that of PACE4. The expression of shRNA targeting PACE4, but not furin, suppressed the expression of the muscle-specific myosin light chain (MLC). Interestingly, reduced expression of MLC was restored following treatment with recombinant mature IGF-II. Finally, we demonstrated that the PI3K inhibitor LY294002 blocked the induction of PACE4 mRNA, a result not observed when another myogenic differentiation inhibitor, SB203580 (p38 MAP kinase inhibitor), was employed, indicating the presence of a positive feedback loop regulating PACE4 expression. These results suggest that PACE4 plays an important role in myogenic differentiation through its association with the IGF-II pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19520771     DOI: 10.1093/jb/mvp090

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  12 in total

1.  Enhanced aggressiveness of benzopyrene-induced squamous carcinomas in transgenic mice overexpressing the proprotein convertase PACE4 (PCSK6).

Authors:  Daniel E Bassi; Jonathan Cenna; Jirong Zhang; Edna Cukierman; Andres J Klein-Szanto
Journal:  Mol Carcinog       Date:  2014-05-21       Impact factor: 4.784

2.  Estrogen stimuli promote osteoblastic differentiation via the subtilisin-like proprotein convertase PACE4 in MC3T3-E1 cells.

Authors:  Hyejin Kim; Atsushi Tabata; Toshifumi Tomoyasu; Tomomi Ueno; Shigeto Uchiyama; Keizo Yuasa; Akihiko Tsuji; Hideaki Nagamune
Journal:  J Bone Miner Metab       Date:  2014-02-21       Impact factor: 2.626

3.  Latent transforming growth factor beta-binding proteins-2 and -3 inhibit the proprotein convertase 5/6A.

Authors:  Xiaowei Sun; Rachid Essalmani; Delia Susan-Resiga; Annik Prat; Nabil G Seidah
Journal:  J Biol Chem       Date:  2011-06-23       Impact factor: 5.157

4.  Expression of paired basic amino acid-cleaving enzyme 4 (PACE4) correlated with prognosis in non-small cell lung cancer (NSCLC) patients.

Authors:  Yun-En Lin; Qi-Nian Wu; Xiao-Dong Lin; Guang-Qiu Li; Ya-Jie Zhang
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

5.  Role of proprotein convertases in prostate cancer progression.

Authors:  Frédéric Couture; François D'Anjou; Roxane Desjardins; François Boudreau; Robert Day
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

6.  The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation.

Authors:  Julia Durzyńska; Anastassios Philippou; Becky K Brisson; Michelle Nguyen-McCarty; Elisabeth R Barton
Journal:  Endocrinology       Date:  2013-02-13       Impact factor: 4.736

Review 7.  Optimizing IGF-I for skeletal muscle therapeutics.

Authors:  Anastassios Philippou; Elisabeth R Barton
Journal:  Growth Horm IGF Res       Date:  2014-06-19       Impact factor: 2.372

8.  The proprotein convertase furin is required for trophoblast syncytialization.

Authors:  Z Zhou; Q Zhang; X Lu; R Wang; H Wang; Y-L Wang; C Zhu; H-Y Lin; H Wang
Journal:  Cell Death Dis       Date:  2013-04-18       Impact factor: 8.469

9.  Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion.

Authors:  Hugo Gagnon; Sarah Refaie; Sandra Gagnon; Roxane Desjardins; Michel Salzet; Robert Day
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

10.  PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.

Authors:  Frédéric Couture; Christine Levesque; Véronique Dumulon-Perreault; Samia Ait-Mohand; François D'Anjou; Robert Day; Brigitte Guérin
Journal:  Neoplasia       Date:  2014-08       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.